{
     "PMID": "28595105",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180103",
     "LR": "20180103",
     "IS": "1558-1497 (Electronic) 0197-4580 (Linking)",
     "VI": "57",
     "DP": "2017 Sep",
     "TI": "Docosahexaenoic acid prevents cognitive deficits in human apolipoprotein E epsilon 4-targeted replacement mice.",
     "PG": "28-35",
     "LID": "S0197-4580(17)30158-6 [pii] 10.1016/j.neurobiolaging.2017.05.003 [doi]",
     "AB": "At a population level, dietary consumption of fish rich in docosahexaenoic acid (DHA) is associated with prevention of cognitive decline but this association is not clear in carriers of the apolipoprotein E epsilon 4 allele (E4). Plasma and liver DHA concentrations show significant alterations in E4 carriers, in part corrected by DHA supplementation. However, whether DHA sufficiency in E4 carriers has consequences on cognition is unknown. Mice expressing human E4 or apolipoprotein E epsilon 3 allele (E3) were fed either a control diet or a diet containing DHA for 8 months and cognitive performance was tested using the object recognition test and the Barnes maze test. In E4 mice fed the control diet, impaired memory was detected and arachidonic acid concentrations were elevated in the hippocampus compared to E3 mice fed the control diet. DHA consumption prevented memory decline and restored arachidonic acid concentrations in the hippocampus of E4 mice. Our results suggest that long-term high-dose DHA intake may prevent cognitive decline in E4 carriers.",
     "CI": [
          "Copyright (c) 2017 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Chouinard-Watkins, Raphael",
          "Vandal, Milene",
          "Leveille, Pauline",
          "Pincon, Anthony",
          "Calon, Frederic",
          "Plourde, Melanie"
     ],
     "AU": [
          "Chouinard-Watkins R",
          "Vandal M",
          "Leveille P",
          "Pincon A",
          "Calon F",
          "Plourde M"
     ],
     "AD": "Research Center on Aging, Centre integre universitaire de sante et de services sociaux de l'estrie-Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Canada; Faculte de Medecine et des Sciences de la Sante, Universite de Sherbrooke, Sherbrooke, Canada; Department of Physiology, Universite de Sherbrooke, Sherbrooke, Canada; Institute of Nutrition and Functional Foods, Quebec City, Canada. Institute of Nutrition and Functional Foods, Quebec City, Canada; Faculte de Pharmacie, Universite Laval, Quebec City, Canada; Neurosciences Axis, Centre hospitalier universitaire de Quebec Research Center, Quebec City, Canada. Research Center on Aging, Centre integre universitaire de sante et de services sociaux de l'estrie-Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Canada; Faculte de Medecine et des Sciences de la Sante, Universite de Sherbrooke, Sherbrooke, Canada; Institute of Nutrition and Functional Foods, Quebec City, Canada. Research Center on Aging, Centre integre universitaire de sante et de services sociaux de l'estrie-Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Canada; Faculte de Medecine et des Sciences de la Sante, Universite de Sherbrooke, Sherbrooke, Canada; Institute of Nutrition and Functional Foods, Quebec City, Canada. Institute of Nutrition and Functional Foods, Quebec City, Canada; Faculte de Pharmacie, Universite Laval, Quebec City, Canada; Neurosciences Axis, Centre hospitalier universitaire de Quebec Research Center, Quebec City, Canada. Research Center on Aging, Centre integre universitaire de sante et de services sociaux de l'estrie-Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Canada; Faculte de Medecine et des Sciences de la Sante, Universite de Sherbrooke, Sherbrooke, Canada; Institute of Nutrition and Functional Foods, Quebec City, Canada; Department of Medicine, Universite de Sherbrooke, Sherbrooke, Canada. Electronic address: Melanie.plourde2@usherbrooke.ca.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170510",
     "PL": "United States",
     "TA": "Neurobiol Aging",
     "JT": "Neurobiology of aging",
     "JID": "8100437",
     "RN": [
          "0 (Apolipoprotein E4)",
          "25167-62-8 (Docosahexaenoic Acids)",
          "27YG812J1I (Arachidonic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "*Apolipoprotein E4",
          "Arachidonic Acid/metabolism",
          "Cognitive Dysfunction/*genetics/metabolism/*prevention & control",
          "*Dietary Supplements",
          "Docosahexaenoic Acids/*administration & dosage/*metabolism",
          "Female",
          "Hippocampus",
          "Male",
          "Mice, Inbred C57BL"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Apolipoprotein E epsilon 4",
          "Arachidonic acid",
          "Cholesterol",
          "Cognitive decline",
          "Docosahexaenoic acid",
          "Hippocampus"
     ],
     "EDAT": "2017/06/09 06:00",
     "MHDA": "2018/01/04 06:00",
     "CRDT": [
          "2017/06/09 06:00"
     ],
     "PHST": [
          "2016/10/30 00:00 [received]",
          "2017/04/25 00:00 [revised]",
          "2017/05/02 00:00 [accepted]",
          "2017/06/09 06:00 [pubmed]",
          "2018/01/04 06:00 [medline]",
          "2017/06/09 06:00 [entrez]"
     ],
     "AID": [
          "S0197-4580(17)30158-6 [pii]",
          "10.1016/j.neurobiolaging.2017.05.003 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neurobiol Aging. 2017 Sep;57:28-35. doi: 10.1016/j.neurobiolaging.2017.05.003. Epub 2017 May 10.",
     "term": "hippocampus"
}